Murine typhus is a common cause of acute febrile illness in Bandung, Indonesia

PLoS One. 2023 Jul 7;18(7):e0283135. doi: 10.1371/journal.pone.0283135. eCollection 2023.

Abstract

Murine typhus (MT), an infection caused by the gram-negative bacteria Rickettsia typhi (R. typhi), is a significant cause of acute febrile illness (AFI) in Southeast Asia but is rarely reported in Indonesia. The current study aimed to describe the clinical characteristics of MT cases in Bandung, West Java. Non-confirmed AFI cases (n = 176) from a prospective cohort study of whom paired serum samples (acute (T1), midterm (T2), or convalescent (T3)) were available were screened using MT serology. IgG against R. typhi was detected in the T2 or T3 samples using an in-house ELISA. Positive IgG samples were further screened for the presence of IgM. If both IgM and IgG were positive, the endpoint titer of T1, T2, or T3 was determined. In cases with a fourfold increase in titer, real-time PCR of T1 samples was performed to detect R. typhi DNA. In total, 71/176 (40.3%) patients tested positive for IgG antibody, and 26 AFI cases were confirmed as MT (23 cases by PCR, 3 cases by fourfold titer increased IgG or IgM titer). The most common clinical symptoms in the confirmed cases were headache (80%), arthralgia (73%), malaise (69%), and myalgia (54%). In these cases, the presumptive clinical diagnoses were typhoid fever (43.2%), dengue (38.5%), and leptospirosis (19.2%). MT was not considered in any of the patients, and no patients received doxycycline. These findings confirmed that MT is an important cause of AFI in Indonesia. MT should be included in the differential diagnosis of AFI, and empirical treatment with doxycycline should be considered.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Doxycycline / therapeutic use
  • Fever / etiology
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M
  • Indonesia / epidemiology
  • Mice
  • Prospective Studies
  • Rickettsia typhi
  • Typhus, Endemic Flea-Borne* / complications
  • Typhus, Endemic Flea-Borne* / diagnosis
  • Typhus, Endemic Flea-Borne* / epidemiology

Substances

  • Doxycycline
  • Immunoglobulin G
  • Immunoglobulin M

Grants and funding

This project was funded by Kementerian Riset, Teknologi dan Pendidikan Tinggi Republik Indonesia through Penelitian Dasar Unggulan Perguruan Tinggi (PDUPT) grant funding year 2018-2019, grant number 3670/UN6.C/LT/2018 and 3854/UN6.C/LT/2019. SFR is supported by a scholarship from The Indonesia Endowment Fund for Education (LPDP). Sysmex Corporation provides funding for the conduction of the fever cohort. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.